Skip to content

Pulian Ointment in Treating Psoriasis of Blood-Heat Syndrome: a multi-center randomized, double-blind, placebo-controlled clinical study

safety and efficacy of clinical research of Pulian Ointment in Treating Psoriasis of Blood-Heat Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002054
Enrollment
Unknown
Registered
2012-03-27
Start date
2010-04-04
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

treatment group:Pulian Ointment
control group:Placebo

Sponsors

Traditional Chinese Medicine University Of Guangzhou
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. outpatient or hospital patients with psoriasis vulgaris who are 18 to 65 years old; 2. Accord with Traditional Chinese medicine with psoriasis blood heat syndromes diagnosis standards; 3. Nearly a week without treatment; 4. Sign informed consent certificates; 5. lesions less than 30% area of the body.

Exclusion criteria

Exclusion criteria: 1. Pregnancy and childbirth infections and trauma stress situation; 2. person who accepted system application or local topical corticosteroids and immunosuppressant nearly one week; 3. person who has severe kidney disease and heart mental illness; 4. person who was systemic or local contact allergy with any of this medicine or matrix components; 5. arthropathic,Pustular or erythrodermic psoriasis.

Design outcomes

Primary

MeasureTime frame
PASI scores;lesions single symptoms evaluation;Itch ratings;HAMA;quality of life score symptom score;

Secondary

MeasureTime frame
TCM syndrome score;

Countries

China

Contacts

Public ContactYanping Bai
zhi@tsinghua.edu.cn+86 13910758509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 10, 2026